In vivo characterisation of novel efficacious muscarinic receptor agonists

This publication has 13 references indexed in Scilit:

• Direct measurement of muscarinic agents in the central nervous system of mice using ex vivo binding
  European Journal of Pharmacology, 1989
• No response to high‐dose muscarinic agonist therapy in Alzheimer's disease
  Neurology, 1988
• Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo‐M ratio as an index of efficacy at cortical muscarinic receptors
  British Journal of Pharmacology, 1988
• Pharmacological differences between two muscarinic responses of the rat superior cervical ganglion in vitro
  British Journal of Pharmacology, 1987
• The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist
  European Journal of Pharmacology, 1986
• Receptor reserve as a tissue misnomer
  Trends in Pharmacological Sciences, 1986
• Physostigmine and Arecoline: Effects of Intravenous Infusions in Alzheimer Presenile Dementia
  The British Journal of Psychiatry, 1981
• Cholinomimetic Treatment Fails to Improve Memory Disorders
  New England Journal of Medicine, 1980
• SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
  Published by Elsevier ,1976
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973